Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer Immunol Res. 2015 May 13;3(8):936–945. doi: 10.1158/2326-6066.CIR-15-0053

Figure 3. Cetuximab treatment increases IFNγ receptor 1 expression.

Figure 3

JHU-029, PCI-15B, JHU-028, JHU-022, EGFR+ HNC cells, and MCF-7 EGFRlow/− breast cancer cells were incubated with cetuximab (10 µg/ml, 72h) and levels of IFNγ receptor α chain (CD119) (A-B), and EGFR expression (A,C) were determined by FACS. Results represent mean +/− SEM from three independent experiments. (*P≤0.05, ***P≤0.0001)